BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 28379073)

  • 41. Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.
    Kon T; Hikichi H; Ueno T; Suzuki C; Nunomura J; Kaneko K; Takahashi T; Nakashima I; Tomiyama M
    Intern Med; 2018 Nov; 57(22):3307-3312. PubMed ID: 29780155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
    Di Pauli F; Berger T
    Front Immunol; 2018; 9():2753. PubMed ID: 30555462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders.
    Rovira À; Vidal-Jordana A; Auger C; Sastre-Garriga J
    Neuroimaging Clin N Am; 2024 Aug; 34(3):399-420. PubMed ID: 38942524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature.
    Ikeda A; Watanabe Y; Kaba H; Kaneko K; Takahashi T; Takeshita S
    Brain Dev; 2019 Apr; 41(4):367-372. PubMed ID: 30447856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.
    Salama S; Khan M; Levy M; Izbudak I
    Mult Scler Relat Disord; 2019 Apr; 29():15-22. PubMed ID: 30658259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical utility of anti-MOG antibody testing in a Danish cohort.
    Papp V; Langkilde AR; Blinkenberg M; Schreiber K; Jensen PEH; Sellebjerg F
    Mult Scler Relat Disord; 2018 Nov; 26():61-67. PubMed ID: 30227311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
    Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem.
    Adachi T; Yasui K; Takahashi T; Fujihara K; Watanabe Y; Nakashima K
    Intern Med; 2016; 55(10):1351-4. PubMed ID: 27181546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
    Eur J Neurol; 2022 Mar; 29(3):802-809. PubMed ID: 34799965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
    Rees JH; Rempe T; Tuna IS; Perero MM; Sabat S; Massini T; Yetto JM
    Magn Reson Imaging Clin N Am; 2024 May; 32(2):233-251. PubMed ID: 38555139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
    Ramanathan S; Dale RC; Brilot F
    Autoimmun Rev; 2016 Apr; 15(4):307-24. PubMed ID: 26708342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on Pediatric Optic Neuritis.
    Gise RA; Heidary G
    Curr Neurol Neurosci Rep; 2020 Mar; 20(3):4. PubMed ID: 32124097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
    Ikeda K; Kiyota N; Kuroda H; Sato DK; Nishiyama S; Takahashi T; Misu T; Nakashima I; Fujihara K; Aoki M
    Mult Scler; 2015 Apr; 21(5):656-9. PubMed ID: 25257613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
    Kezuka T; Ishikawa H
    Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.
    Lotan I; Brody J; Hellmann MA; Bialer O; Ganelin-Cohen E; Michaeli N; Marignier R; Stiebel-Kalish H
    J Neurol; 2018 Sep; 265(9):1985-1988. PubMed ID: 29938337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: A case study.
    Haddad N; Roussel B; Pelcovits A; Rizvi S
    Mult Scler Relat Disord; 2019 Sep; 34():14-16. PubMed ID: 31226544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures.
    Gutman JM; Kupersmith M; Galetta S; Kister I
    J Neurol Sci; 2018 Apr; 387():170-173. PubMed ID: 29571858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.